A randomized trial of FOLFIRI versus docetaxel and cisplatin as a second-line chemotherapy after failure of first-line chemotherapy in advanced gastric cancer

Authors :: Kang Lee Yong
Seok Moon Hee
Eun Kim Sung
Chul Park Jun
Sun Kim Eun
seok jang jin
Kil Lee Sang
Young Cho Joo
Hyung Lee Si
Source :: Annals of Oncology. 28:iii34
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Cisplatin
Oncology
medicine.medical_specialty
business.industry
Hematology
Advanced gastric cancer
Second line chemotherapy
law.invention
Randomized controlled trial
Docetaxel
law
Internal medicine
medicine
FOLFIRI
First line chemotherapy
business
medicine.drug

Full Text Access

Tools